A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects
Latest Information Update: 31 Oct 2025
At a glance
- Drugs Amisodin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors PRG Science & Technology
Most Recent Events
- 31 Oct 2025 New trial record